The Biotech Growth Trust Plc - Transaction in Own Shares
PR Newswire
London, February 7
For immediate release
7 February 2020
THE BIOTECH GROWTH TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
Notification is given, pursuant to the authority granted at a General Meeting of the Company held on 27 January 2020 to make market purchases of the Company's own shares up to an aggregate maximum of 6,127,729 that a market total of 204,223 Ordinary shares of 25p each in the capital of the Company were purchased today for cancellation by the Company at a price of 953.24 pence per share.
Following this transaction and in conformity with the provisions of the Transparency Directive, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 40,199,614. The Company does not currently hold any Ordinary shares in treasury.
The figure of 40,199,614 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 170 4913
